ArticleThe American journal of case reports2026
Transient Ischemic Attack Progressing to Top-of-the-Basilar Syndrome: A Case Report.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Top-of-the-basilar syndrome (TOBS) is a rare but clinically heterogeneous posterior circulation disorder characterized by acute ischemia affecting 2 or more territories supplied by the distal basilar artery, including the thalami, midbrain, occipital lobes, medial temporal lobes, and cerebellum. Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) is an established treatment for eligible patients with TOBS, and reports of transient coma induced during rt-PA infusion remain exceedingly scarce. CASE REPORT A 77-year-old man with non-valvular atrial fibrillation and hypertension presented with transient visual hallucinations-initially diagnosed as a transient ischemic attack. Emergency head and neck computed tomography angiography revealed severe stenosis-occlusion of the left posterior cerebral artery P1 segment. Within 12 hours, he developed dysarthria and right hemiparesis, prompting intravenous thrombolysis with rt-PA (0.9 mg/kg). Fifty minutes after infusion, he experienced abrupt, self-limiting loss of consciousness, without evidence of intracranial hemorrhage on emergent computed tomography. Subsequent magnetic resonance imaging confirmed incomplete TOBS, showing acute infarcts in bilateral thalami, left hippocampus, and right cerebellar hemisphere. Magnetic resoance angiography demonstrated resolution of the prior P1 stenosis but new suspicious narrowing in the distal P2 segment. CONCLUSIONS This case suggests that the clinical symptoms of cardiogenic TOBS change rapidly and are diverse. This diversity can occur before and during intravenous thrombolytic therapy. If neurological deterioration occurs during the use of thrombolytic agents, it is necessary to promptly identify whether it is stroke progression or hemorrhagic transformation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.